Goals and Initiatives
The Chugai Group has set environmental goals and health and productivity management goals to continuously promote environmental protection activities and health and safety activities from a medium-to-long-term perspective.
Mid-Term Environmental Goals 2030
The Chugai Group will contribute to the realization of a sustainable global environment by setting mid-term environmental goals for the three issues identified as material: climate change countermeasures, use of renewable/recycled resources, and protection of biodiversity, with the final year set for 2030. Furthermore, since climate change is the most critical global theme and requires long-term, large-scale countermeasures, we have also established long-term goals for some items, with 2050 as the final year.
| Material issues | Item | KPI (Base year 2019) |
|---|---|---|
| Climate change countermeasures (prevention of global warming) |
Scope 1+2*1 CO2 emissions |
40% reduction by 2025 60～75% reduction by 2030 Zero emissions by 2050 |
| Scope 1+2*1 Energy reduction |
5% reduction by 2025*2 15% reduction by 2030*2 |
|
| Sustainable electricity ratio | 100% by 2025 | |
| Fuel consumption by MR vehicles | 35% reduction by 2025 75% reduction by 2030 |
|
| Halogenated hydrocarbons | 25% reduction by 2025 100% reduction by 2030 (Base year 2020) |
|
| Scope 3*1 CO2 emissions |
30% reduction by 2030 | |
| Use of renewable/recycled resources (Resource conservation/waste management) |
Industrial waste reduction | 5% reduction by 2025*2 10% reduction by 2030*2 |
| Plastic waste reduction | 5% reduction by 2025*2 10% reduction by 2030*2 |
|
| Water resource conservation (water withdrawn) | 15% reduction by 2030*2 | |
| Protection of Biodiversity (Reduction of environmental load) |
Chemical substance management (SVHC*3) |
After 2021, manufacturing processes without using SVHC-listed chemicals are established for all Chugai original candidate molecules by commercial productions. |
| Hazardous waste reduction | 5% reduction by 2025*2 10% reduction by 2030*2 |
- *1 Scope 1: Direct emissions, Scope 2: Indirect emissions from the generation of purchased energy, Scope 3: Indirect emissions other than Scope 1 and Scope 2 (Target added in 2021)
- *2 Per total floor area (Excluding leased properties)
- *3 Substances of Very High Concern
Environmental Action Plans
As we work toward achieving our mid-term environmental goals, we have implemented an ongoing program of environmental and safety activities that involve setting yearly action goals or plans for each item based on the mid-term plan, evaluating the results, and reflecting those results in the following year’s plan.
2022 Action Plan and Performance/2023 Action Plan [PDF 131KB]
Industry activities
To promote the reduction of CO2 emissions as the pharmaceutical industry, we participate in the Environmental Issues Subcommittee of the Japan Pharmaceutical Manufacturers Association (JPMA) and the Carbon Neutral Action Plan Working Group (CN Action Plan Working Group) of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ). In particular, we participate in the CN Action Plan WG as a leader company, contributing to the promotion of initiatives to reduce CO2 emissions.
Mid-term Health and Productivity Management Goals 2030
While promoting health and safety activities under the Environment, Health and Safety (EHS management) system in line with our basic approach, we identified and evaluated issues and established six high-priority items in the area of health and productivity management: cancer; lifestyle-related diseases; mental health; health literacy; workplace safety; and organizational climate. We have set medium to long-term goals in each of these areas and are conducting activities to achieve them by 2030, the final year of the goals.
Mid-term Health and Productivity Management Goals 2030
| Priority Items | Goals | KPI |
|---|---|---|
| Cancer | Early detection Early treatment Support for continuing to work while undergoing treatment |
Cancer screening participation rate of 90% or higher for stomach cancer, colon cancer, lung cancer, breast cancer and cervical cancer Retesting participation rate of 95% or higher Management awareness of the support program for continuing to work while undergoing treatment of 100% |
| Lifestyle-related diseases | Measures for high-risk individuals Reduce worsened health among those with preconditions Reduce transition to the precondition group |
Maintain ratio of high-risk individuals under 1% Maintain ratio of precondition group transitioning to high-risk individuals under 1% Normal group 70% or higher |
| Mental health | Prevention and early detection Support for return to work |
Percentage of high-stress individuals requesting interviews: 2% or more of those tested Maintain stable return to work rate of 80% or higher |
| Health literacy | Awareness reforms Recommendations for behavioral changes |
Implementation of lectures at 100% of facilities Rate of failure to retest of 0% among individuals at high risk for lifestyle diseases |
| Physical safety in the workplace | Health and safety risk reduction Consciousness raising |
Zero major occupational accidents Maintain EHS Audit Plan implementation rate of 100% Implement awareness activities company-wide at all facilities |
| Psychological safety in the workplace | Increase the number of sound organizations Foster a rewarding organizational climate |
Stress checks Fewer than 5% of organizations with an overall health risk score of 120 or higher Environment for making best use of employees: At high-performing enterprise level |
Health management activity plans
To achieve our medium-term health management goals, we set annual goals for each item, evaluate the results of those activities, and reflect those evaluations in activities for the next fiscal year, thereby continuously promoting environmental and safety-related activities.
Results of Health and Productivity Management Initiatives
| Theme | 2021 | 2022 |
|---|---|---|
| Cancer | Cancer screening participation rate: Stomach cancer 87%, Colon cancer 89%, Lung cancer 98%, Breast cancer 90%, Cervical cancer 79% Cancer re-examination rate: 66% |
Cancer screening participation rate: Stomach cancer 88%, Colon cancer 91%, Lung cancer 98%, Breast cancer 91%, Cervical cancer 78% Cancer re-examination rate: 79% |
| Lifestyle-related diseases | Normal group: 64.1% Specific health guidance participation rate: 80.2% (result in 2020) Occupational physician consultation rate by high-risk persons: 100% Appropriate weight maintenance rate: 66.2% Treatment rate for hypertensive patients: 88.0% |
Normal group: 64.5% Specific health guidance participation rate: 80.2% (result in 2021) Occupational physician consultation rate by high-risk persons: 100% Appropriate weight maintenance rate: 66.0% Treatment rate for hypertensive patients: 88.2% |
| Mental health | Stress check participation rate: 84.8% Rate for person with high stress: 8.7% |
Stress check participation rate: 91.6% Rate for person with high stress: 6.2% |
| Smoking | Smoking rate: 11.9% | Smoking rate: 10.6% |
| Health literacy | Rate of lectures implemented at facilities: 62% | Rate of lectures implemented at facilities: 62% |
| Physical safety in the workplace | Audit implementation rate: 100% | Audit implementation rate: 100% |
Results of medical checkups and training
| Initiative | 2021 | 2022 |
|---|---|---|
| Medical examinations | Consultation rate: 100% | Consultation rate: 100% |
| Training | Theme: Mental health Rate of participants: 100% Comprehension rate: 99.7% |
Theme: Cancer Rate of participants: 88.3% Completion rate of comprehension test: 100% |
Trends in health management target indicators
| Measurement item | Measurement method | 2021 | 2022 |
|---|---|---|---|
| Presenteeism (point) | SPQ | 81.0 | 80.0 |
| Absenteeism (day) | Questionnaire to employees | 1.8 | 2.2 |
| Work engagement (deviation value) | New occupational stress simplified survey | 53.5 | 53.6 |
